Latest News for: dlbcl

Edit

Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

Pharmiweb 06 Dec 2025
In EPCORE DLBCL-3, the ORR was 73% in elderly patients with DLBCL treated with first-line, fixed-duration epcoritamab monotherapy who were unable to receive standard anthracycline-based chemotherapy ... EPCORE® DLBCL-3 Trial Results.
Edit

Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL ...

The Joplin Globe 04 Dec 2025
CARLSBAD, Calif.--(BUSINESS WIRE)--Dec 4, 2025-- ... .
Edit

New clinical trial aims to prevent relapse in patients with DLBCL

Watauga Democrat 27 Sep 2025
(BPT) - For many patients diagnosed with diffuse ...
  • 1

Article Search

tools
×
×
×
×